Pharmafile Logo
Pharmafocus logo
Advanced Search

Servier

Showing 15 posts of 26 posts found.

BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design

July 11, 2025
Research and Development BioLabs, BioMed X, Cancer, Oncology, Servier, XSeed Labs, antibody therapy, oncology

BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, located at the Spartners incubator …

News

Servier and Aitia enter into R&D collaboration for pancreatic cancer using Digital Twins

May 18, 2023
Research and Development Aitia, Digital Twins, Oncology, Pancreatic cancer, Servier

French pharmaceutical company Servier and US-based Causal AI and Digital Twins company Aitia have announced a collaboration to create Digital …

News

Servier and MiNA partner to develop neurological disorder treatments

January 22, 2021
Medical Communications MiNA, Servier

Independent pharmaceutical group Servier and RNA activation-focused MiNA Therapeutics have entered a research partnership to identify and develop small activating …

News
shire_image

Shire hands over its oncology franchise to Servier for $2.4bn

August 31, 2018
Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …

News
shire_image

Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal

April 16, 2018
Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical

Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …

News
gavel-1017953_1280

Servier fights fine over antitrust breaches

June 7, 2017
Manufacturing and Production, Research and Development, Sales and Marketing European Commission, Servier, generic

Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust …

News
ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …

Appointment

France Focus: Power without responsibility?

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …

Feature
servier image

Servier slammed over UK trial transparency failure

September 8, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials

Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …

News
servier image

Servier fined €331m by European Commission

July 10, 2014
Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva

The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …

News
Servier image

Servier signs leukaemia deal

February 19, 2014
Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia

French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …

News
servier image

Servier signs cancer partnership

January 29, 2014
Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

News
Amgen image

Amgen signs Servier deal

July 11, 2013
Sales and Marketing Amgen, Servier, heart, procoloran

Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …

News

Boehringer wins contract to make Servier’s gevokizumab

August 7, 2012
Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody

Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …

News

Misinformation charges against Servier dropped

January 30, 2012
Sales and Marketing European Commission, Servier, anti-competitive behaviour

The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026